Valtorcitabine - Combination Drug Therapy for Chronic Hepatitis B
Key Data:
Drug (brand/generic)
Valtorcitabine
Company/licensee
Idenix Pharmaceuticals/ Novartis Pharma
Therapy class
Nucleotide analogue
Product description
Oral L-deoxycytidine
Current indication
Chronic HBV infection
Market sector
Antiinfectives
Development status
Phase II
